Bicara Therapeutics Inc (NASDAQ: BCAX) kicked off on Friday, up 11.50% from the previous trading day, before settling in for the closing price of $16.18. Over the past 52 weeks, BCAX has traded in a range of $7.80-$22.67.
While this was happening, its average annual earnings per share was recorded 37.50%. With a float of $32.06 million, this company’s outstanding shares have now reached $54.61 million.
Bicara Therapeutics Inc (BCAX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Bicara Therapeutics Inc is 43.22%, while institutional ownership is 63.94%. The most recent insider transaction that took place on Nov 21 ’25, was worth 10,981. Before that another transaction happened on Nov 21 ’25, when Company’s Officer proposed sale 12,500 for $18.05, making the entire transaction worth $225,588.
Bicara Therapeutics Inc (BCAX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.39 earnings per share (EPS), lower than consensus estimate (set at -0.28) by -0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
Bicara Therapeutics Inc (NASDAQ: BCAX) Trading Performance Indicators
Take a look at Bicara Therapeutics Inc’s (BCAX) current performance indicators. Last quarter, stock had a quick ratio of 14.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.23, a number that is poised to hit -0.69 in the next quarter and is forecasted to reach -3.05 in one year’s time.
Technical Analysis of Bicara Therapeutics Inc (BCAX)
The latest stats from [Bicara Therapeutics Inc, BCAX] show that its last 5-days average volume of 0.63 million was superior to 0.6 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 78.64%.
During the past 100 days, Bicara Therapeutics Inc’s (BCAX) raw stochastic average was set at 84.78%, which indicates a significant decrease from 97.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.26 in the past 14 days, which was higher than the 0.91 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.30, while its 200-day Moving Average is $12.81. Now, the first resistance to watch is $18.86. This is followed by the second major resistance level at $19.67. The third major resistance level sits at $21.19. If the price goes on to break the first support level at $16.53, it is likely to go to the next support level at $15.01. The third support level lies at $14.20 if the price breaches the second support level.
Bicara Therapeutics Inc (NASDAQ: BCAX) Key Stats
The company with the Market Capitalisation of 988.27 million has total of 54,782K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -68,000 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -36,330 K.
